Permission to use, copy, and distribute content from this web site is hereby granted for non-commercial use only, provided that the above copyright and relevant trademark notice appear in all copies and that the name of Elekta is not used in advertising or publicity pertaining to distribution of this documentation without specific, written prior permission. All images used on this site are owned or licensed by Elekta for use on this site only. Unauthorized use is prohibited.
The site contains information about products which may or may not be available in any particular country, and if applicable, may have received approval or market clearance by a governmental regulatory body for different indications and restrictions in different countries or may be for investigational use only. Each country has specific laws, regulations and medical practices governing the communication of medical or other information about medical products on the Internet. Nothing herein should be construed as a solicitation or promotion for any product or for an indication for any product which is not authorized by the laws and regulations of the country where the reader resides.
The links set out on this web site are provided for your convenience only. The web sites to which the links are provided are not within the control of Elekta. Elekta does not endorse and shall not be responsible in any way for the content, including but not limited to marketing and information, or the availability of such external resources. Elekta shall not, either directly or indirectly, be liable for any damage or loss caused by or in connection with use of such external web sites.
Certain parts of this web-site may only be available through use of a password, provided by Elekta for certain services.
All users who have been granted a password undertake to keep the password in a safe location, to prevent unauthorized persons from gaining access to it. The user who has been granted the password is fully responsible for all activities that occur under his/her password. If Elekta finds reason to believe that unauthorized use of the web site or the password is taking place, Elekta may immediately discontinue the right to access to the web site and cancel the password.
The information on this site is provided for your convenience only and is provided on a strictly "as is" basis without any warranties, express or implied, including but not limited to the implied warranties of merchantability, fitness for a particular purpose, or non-infringement. Elekta makes no representation or warranty that the information contained on this site will be timely or error-free. Elekta shall not be liable for any direct, indirect, incidental, special, consequential or exemplary damages, including, but not limited to damages for loss of profits, goodwill, use data, data or other intangible losses resulting from the use or inability to use the web site or information contained herein.
Yes, you have several choices with respect to cookies. You can modify your browser preferences to accept all cookies, to notify you when a cookie is set, or to reject all cookies. However, if you choose to reject all cookies, you may not be able to the full range of services offered by this web site.
Elekta and its suppliers of third party information expressly disclaim all warranties, of any kind, express or implied, including but not limited to warranties of merchantability or fitness for a particular purpose. Elekta and its suppliers of third party information expressly disclaim responsibility for the accuracy, timeliness or adequacy of the services) or the information furnished thereby. In no event shall Elekta or its suppliers of third party information be liable for any loss or damages arising from the use of the service(s), sequence, accuracy, or completeness of any news, market information, quotations or other information furnished in the information service.. Elekta or its third party information suppliers shall have no liability for lost profits, special or consequential damages, even if Elekta or its information service suppliers had been made aware of such damages.
This web site may include forward-looking statements that involve risks and uncertainties, including technological advances in the medical field, product demand and market acceptance, the effect of economic conditions, the impact of competitive products and pricing, foreign currency exchange rates and other risks detailed in the company's filings with the OM/Stockholm Stock Exchange. These forward-looking statements are made as of the date of publication. All of these forward-looking statements are based on estimates and assumptions made by management of the company and are believed to be reasonable, though are inherently uncertain and difficult to predict. Actual results or experience could differ materially from the forward-looking statements.
Elekta reserves the right at any time and from time to time modify or discontinue, temporarily or permanently, providing the Information (or any part thereof) with or without notice.
Any disputes, lawsuits, or other claims against Elekta or any related person or entity arising from, relating to, or touching upon this web site, the information contained herein and/or statements contained herein shall be construed under and governed by Swedish law. Any action at law, suit in equity, or other judicial proceeding concerning, relating to, or touching upon in any way this web site or the statements contained herein, shall be brought, if at all, only in the country of Sweden with the City Court of Stockholm as the first instance.
All users of this web site acknowledge the right of the specified court to assert personal jurisdiction in any such action and waive and release now and forever any defense to that assertion of jurisdiction that might otherwise exist.
Integrated with MOSAIQ radiation oncology is the MOSAIQ image-enabled electronic medical record (EMR), which supports the entire cancer care team by uniting diverse systems and devices. The ‘Integrating the Healthcare Environment for Radiation Oncology’ (IHE-RO) initiative seeks to improve the practice of radiation oncology through a standardized exchange of information. Working through the IHE-RO, Elekta Software leads the way in promoting open systems standards, leveling the interoperability playing field and affording vendors greater latitude to focus on maximizing efficiency and achieving high patient throughput.
Elekta Software stands side-by-side with you to ensure that you maintain an even higher level of quality care after the Health Insurance Portability and Accountability Act (HIPAA) unfolds and makes its mark on the healthcare world. Elekta Software’s HIPAA Implementation Team is busy keeping pace with developments by analyzing released and proposed regulations and guidance, attending and contributing to user/industry meetings, and reviewing relevant publications.
Read general HIPAA information, read about Elekta Software's HIPAA efforts, view Elekta Software compliance statements, and access helpful HIPAA links.
ISO, EN, and CE Markings, United States: Food and Drug Administration (FDA) information, FDA Pre-Market Notification information, European Community: CE Marking (MDD and MDR) information, Canada: Health Canada information, Australia: Therapeutic Goods Administration (TGA) information, Elekta Software Regulatory Affairs Contact.
Elekta is committed to the security of data collected online. Your privacy is important to us and we recognize your need for reasonable control of personally identifiable information that you provide to Elekta. We qualify personally identifiable information as any information that is associated with your name. The information you provide helps Elekta to better understand your needs and provide you with better service.
Elekta will not sell your personally identifiable information to others. Elekta may share your information with Elekta entities located in other countries and/or business partners in order to help satisfy your business needs.
Elekta aims to provide the highest level of cancer treatment possible, which means combining the most advanced technology with the most effective treatment techniques. In addition to working with industry and academic leaders through collaborative sponsored research programs, Elekta has its own extensive research and development program, which has resulted in a patent portfolio covering many important innovations in cancer care.
The below notices are in compliance with ACA (Affordable Care Act) Section 1557 Non Discrimination regulation The notices refer to: